Deadly Risk? What Ozempic and Wegovy Aren’t Telling Us

Deadly Risk? What Ozempic and Wegovy Aren’t Telling Us

The first tenant in Risk Communications is Perception = Reality (P = R).

Imagine the fallout if patients suddenly discovered their miracle weight-loss drug was inspired by the venom of one of North America’s most feared lizards – the Gila monster.

But that’s precisely the fascinating origin story behind Ozempic and Wegovy that most people never hear.

In the mid-1990s, Dr. John Eng discovered something remarkable: a compound called exendin-4 in Gila monster venom that stimulates insulin production. This deadly lizard’s bite, which can kill small prey, contained the key to revolutionizing diabetes treatment and weight management.

At first, big pharmaceutical companies didn’t want to touch it.

For three years, Eng faced rejection after rejection. The risk-averse industry saw “deadly venom” and ran the other direction. Who wants to explain to shareholders – or patients – that their breakthrough medication originated from a poisonous reptile?

The perception problem was real.

Venom equals danger in most minds. Never mind that countless life-saving medications come from unlikely sources – from heart drugs derived from snake venom to cancer treatments from toxic plants.

The pharmaceutical industry’s initial reluctance perfectly illustrates how perception shapes reality in healthcare.

Eng’s employer, the VA, showed no interest in patenting his discovery. He filed the patent himself and spent years trying to convince anyone to develop it. Finally, in 1996, persistence paid off when he presented his findings at the American Diabetes Association meeting.

The irony? The same compound that makes Gila monster venom potentially lethal to small animals became the foundation for drugs generating billions in revenue and transforming millions of lives. Exendin-4 works similarly to human GLP-1 hormone, regulating blood sugar and promoting satiety.

Today’s synthetic versions are completely safe – no lizards harmed, no venom extracted.

Yet the perception challenge remains. How many breakthrough treatments never see daylight because their origins seem too unconventional, too risky, or simply too weird for public acceptance?

The lesson isn’t just about drug development – it’s about innovation itself. Sometimes the most transformative solutions come from the most unexpected places.

Whether it’s deadly venom leading to life-saving medicine or unconventional approaches solving stubborn problems, perception often determines what we’re willing to explore.

Now that we know it works, maybe we can get over the jitters of knowing that our weight-loss wonder drug has its roots in one of nature’s most feared creatures. After all, sometimes the best medicine comes from the most surprising sources.

What’s your take? Are we too quick to dismiss innovations based on their unconventional origins?

(Source: Popular Mechanics. Special thanks to Dr. Vince Covello)